FIGURE 2.

Most patients found the decision to undergo AD CSF biomarker testing an easy one to make and a majority reported positive feelings after learning their biomarker test results. (A) Patients’ rating for the ease/difficulty of making the decision to undergo testing and (B) primary reasons for “easy” decision‐making. (C) Patients’ feelings post‐result disclosure, (D) care partners’ perspective of the patients’ feelings post‐result disclosure, (E) primary reasons for patients’ reporting overall positive feelings, and (F) primary reasons for patients’ reporting mixed or overall negative feelings. Values represent the percentage of relevant patient or care partner responses. AD, Alzheimer's disease; CSF, cerebrospinal fluid.